SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001140361-16-046992
Filing Date
2016-01-06
Accepted
2016-01-06 19:05:43
Documents
1
Period of Report
2015-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4/A doc1.html 4/A  
1 FORM 4/A doc1.xml 4/A 4092
  Complete submission text file 0001140361-16-046992.txt   5637
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TEKMIRA PHARMACEUTICALS CORP 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address
Abrams Michael J. (Reporting) CIK: 0001628291 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-34949 | Film No.: 161328388